The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
BioNTech SE(NASDAQ:BNTX) 
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is involved in the developing of FixVac product candidates, including BNT111, which is in Phase I clinical trial for advance melanoma; BNT112 that is in Phase I/IIa...
Website: http://www.biontech.de
Founded: 2008
Full Time Employees: 1,800
CEO / Founder: Ugur Sahin
Sector: Healthcare
Industry: Biotechnology
BioNTech SE Number of Twitter Followers
BioNTech SE Days Payable Outstanding ttm (DPO)
BioNTech SE Days Receivable Outstanding ttm (DSO)
BioNTech SE Days Inventory Outstanding ttm (DIO)
BioNTech SE Op Cashflow Per Share ttm
BioNTech SE Free Cashflow Per Share ttm
BioNTech SE Cash Per Share ttm
BioNTech SE P/S ratio ttm
BioNTech SE (GAAP) P/E ratio ttm
BioNTech SE P/B ratio ttm
No extra charts and metrics for this ticker.